allulose glp 1 agonist effect Allulose in human diet: the knowns and the unknowns GLP-1-based therapies for type 2

Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management

Ozempic, Wegovy, Zepbound, and Mounjaro are GLP-1 medications that help lower blood sugar

Berberine is not a GLP-1 agonist, though both compounds influence metabolic pathways

For those seeking a more natural approach, certain herbs and plant-based nutrients have been traditionally used to support the bodys own production and activity of GLP-1, helping to promote satiety and balanced appetite without relying on synthetic drugs

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated